ID22878A - Komposisi aktif secara terapi - Google Patents

Komposisi aktif secara terapi

Info

Publication number
ID22878A
ID22878A IDW991447A ID991447A ID22878A ID 22878 A ID22878 A ID 22878A ID W991447 A IDW991447 A ID W991447A ID 991447 A ID991447 A ID 991447A ID 22878 A ID22878 A ID 22878A
Authority
ID
Indonesia
Prior art keywords
active composition
composition therapy
therapy
active
composition
Prior art date
Application number
IDW991447A
Other languages
English (en)
Inventor
Fiona Kate Gardiner
Original Assignee
Reckitt & Colman Prodicts Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colman Prodicts Ltd filed Critical Reckitt & Colman Prodicts Ltd
Publication of ID22878A publication Critical patent/ID22878A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW991447A 1997-06-10 1998-06-08 Komposisi aktif secara terapi ID22878A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9711962.2A GB9711962D0 (en) 1997-06-10 1997-06-10 Therapeutically active compositions

Publications (1)

Publication Number Publication Date
ID22878A true ID22878A (id) 1999-12-16

Family

ID=10813845

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991447A ID22878A (id) 1997-06-10 1998-06-08 Komposisi aktif secara terapi

Country Status (17)

Country Link
US (1) US6201014B1 (id)
EP (1) EP0988028B1 (id)
JP (1) JP2002513418A (id)
KR (1) KR20010013618A (id)
CN (1) CN1198594C (id)
AR (1) AR012960A1 (id)
AT (1) ATE262892T1 (id)
AU (1) AU737606B2 (id)
BR (1) BR9809994A (id)
CA (1) CA2291796C (id)
DE (1) DE69822822T2 (id)
GB (3) GB9711962D0 (id)
HU (1) HUP0004245A2 (id)
ID (1) ID22878A (id)
PL (1) PL337337A1 (id)
WO (1) WO1998056356A1 (id)
ZA (1) ZA984920B (id)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790207B2 (en) * 1998-06-04 2004-09-14 Curon Medical, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat disorders of the gastrointestinal tract
US20110071468A1 (en) * 1998-06-04 2011-03-24 Mederi Therapeutics, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
US6802841B2 (en) * 1998-06-04 2004-10-12 Curon Medical, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
GB9812426D0 (en) * 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB9925127D0 (en) * 1999-10-22 1999-12-22 Pharmacia & Upjohn Spa Oral formulations for anti-tumor compounds
US20030119916A1 (en) * 2000-03-01 2003-06-26 David Fowler Treatment of functional gastrointestinal disorders
US6759064B2 (en) 2001-02-22 2004-07-06 Purdue Research Foundation Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
US7192612B2 (en) * 2001-02-22 2007-03-20 Purdue Research Foundation Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
US6428822B1 (en) 2001-04-03 2002-08-06 Chengzhi Life Science Company, Ltd. Extracts of mixed arctium lappa L., carrot and whole radish for treating hypertension, constipation and detoxification
US6682759B2 (en) * 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
US7198804B2 (en) * 2002-04-12 2007-04-03 Helixir Co., Ltd. Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases
US20040161481A1 (en) * 2002-12-18 2004-08-19 Algorx Administration of capsaicinoids
AU2003299691B2 (en) 2002-12-18 2008-06-05 Algorx Pharmaceuticals, Inc. Administration of capsaicinoids
US20050085652A1 (en) * 2003-04-08 2005-04-21 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
US20100159000A1 (en) * 2003-11-10 2010-06-24 Lundeen Sr James E Medicine for treating gastrointestinal disorder including fecal incontinence
AT413646B (de) * 2004-04-02 2006-04-15 Hammer Johann Dr Verwendung von capsaicin und/oder capsaicinoiden
US20050277657A1 (en) * 2004-06-15 2005-12-15 Dusan Ninkov Method of protection of biologically active essential oils and pharmaceutical composition for weight control and enhance fat burning in adults, adolescents and children
WO2006058140A2 (en) * 2004-11-24 2006-06-01 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
WO2006069451A1 (de) 2004-12-28 2006-07-06 Mestex Ag Verwendung von resiniferatoxin (rtx) für die herstellung eines mittels zur behandlung von gelenkschmerzen und verfahren zur applikation dieses mittels
EP2096927B1 (en) 2006-10-27 2012-10-10 BMB Patent Holding Corporation Therapeutic compositions and methods of treatment with capsianoside-type compounds
CN101835500B (zh) * 2007-08-29 2014-05-28 吸附剂治疗学公司 具有可变抗衡离子含量的吸收性聚合物组合物及其制备方法和用途
KR20090047637A (ko) * 2007-11-08 2009-05-13 재단법인서울대학교산학협력재단 커큐민 또는 이의 약학적으로 허용가능한 염을유효성분으로 함유하는 통증 예방 및 치료용 조성물
HUP0700755A2 (en) * 2007-11-26 2009-08-28 Pannonpharma Gyogyszergyar Pharmaceutical compositions containing capsaicionoid and non-steroidal anti-inflammatory drug
WO2010011597A2 (en) * 2008-07-22 2010-01-28 Mayo Foundation For Medical Education And Research Treatment of obesity and related disorders
US20110200669A1 (en) * 2010-02-15 2011-08-18 Winston Laboratories, Inc. Method and compositions of civamide to treat disease of the intestines
KR101378973B1 (ko) * 2012-04-13 2014-03-28 한미약품 주식회사 구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법
CN103027901B (zh) * 2012-12-11 2014-11-12 广东药学院 一种载辣椒素壳聚糖微球肠溶片及其制备方法
US10092528B2 (en) 2013-03-13 2018-10-09 Altria Client Services Llc Application of encapsulated capsaicin and analogues thereof for controlling calorie intake
US9289418B2 (en) 2013-03-15 2016-03-22 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
CA2903493C (en) 2013-03-15 2022-05-31 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
AU2014380905A1 (en) 2014-01-30 2016-09-08 Omniactive Health Technologies Limited Composition of oily, pungent and odoriferous substances and a process of preparation thereof
AU2015301596B2 (en) 2014-08-13 2020-04-16 Cedars-Sinai Medical Center Anti-methanogenic compositions and uses thereof
WO2016161085A1 (en) * 2015-04-01 2016-10-06 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof
AU2019457560B2 (en) * 2019-07-18 2025-04-10 Dignify Therapeutics, Llc Compositions and methods for inducing defecation
KR20230002560A (ko) * 2020-04-15 2023-01-05 그뤼넨탈 게엠베하 레시니페라톡신 조성물
WO2022155273A1 (en) * 2021-01-15 2022-07-21 Dignify Therapeutics, Llc Compositions and methods for inducing defecation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2207705A1 (en) 1972-11-24 1974-06-21 Marconnet Rene Deodorisation of body odours - by liberation of odoriferous substances in the intestines
EP0015334B1 (en) * 1977-08-04 1982-05-19 J.B. Tillott Limited Carminative preparations containing peppermint oil or its active components
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US5403868A (en) 1988-12-23 1995-04-04 Sandoz Ltd. Capsaicin derivatives
HU206082B (en) * 1988-12-23 1992-08-28 Sandoz Ag Process for producing capsaicin derivatives and pharmaceutical compositions comprising such compounds
US5063060A (en) * 1989-12-19 1991-11-05 Cisco Limited Partnership Compositions and method for treating painful, inflammatory or allergic disorders
DE4137540A1 (de) 1991-11-14 1993-05-19 Steigerwald Arzneimittelwerk Verwendung von praeparaten der curcuma-pflanzen
US5431914A (en) 1992-04-17 1995-07-11 Adekunle; Michael Method of treating an internal condition by external application of capsaicin without the need for systemic absorption
CA2136174A1 (en) * 1992-05-21 1993-11-25 Jeff J. Staggs Therapeutic uses of pungent botanicals and their related compounds
US5762963A (en) 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
DE69624818T2 (de) * 1995-07-14 2003-04-10 Sabinsa Corp., Piscataway Lebenschützende mittel, verfahren zu deren verwendung sowie extraktionsverfahren für curcuminoide

Also Published As

Publication number Publication date
EP0988028A1 (en) 2000-03-29
US6201014B1 (en) 2001-03-13
WO1998056356A1 (en) 1998-12-17
CA2291796C (en) 2008-03-25
PL337337A1 (en) 2000-08-14
ZA984920B (en) 1999-07-01
DE69822822D1 (de) 2004-05-06
DE69822822T2 (de) 2005-01-13
EP0988028B1 (en) 2004-03-31
ATE262892T1 (de) 2004-04-15
KR20010013618A (ko) 2001-02-26
CN1198594C (zh) 2005-04-27
GB9811819D0 (en) 1998-07-29
BR9809994A (pt) 2000-08-01
JP2002513418A (ja) 2002-05-08
GB9827192D0 (en) 1999-02-03
GB9711962D0 (en) 1997-08-06
GB2332147B (en) 1999-10-27
AU7782998A (en) 1998-12-30
CA2291796A1 (en) 1998-12-17
CN1259863A (zh) 2000-07-12
AU737606B2 (en) 2001-08-23
HUP0004245A2 (hu) 2001-08-28
GB2332147A (en) 1999-06-16
AR012960A1 (es) 2000-11-22

Similar Documents

Publication Publication Date Title
ID22878A (id) Komposisi aktif secara terapi
ID24118A (id) Terapi gabungan
IS5425A (is) Læknislyf
ID24275A (id) Terapi kombinasi
NO992806D0 (no) Terapeutiske midler
ID25533A (id) Formulasi 2-metil-tieno-benzodiazepin
ID27841A (id) Turunan-turunan biaril terapeutik
TR199501137A2 (tr) Terapötik olarak aktif bilesenler
DE69725373D1 (de) Aktives Implantat
DE59802860D1 (de) Desinfektionsmittel
MA24473A1 (fr) Formulations
ID25508A (id) Komposisi dematologis
NO980546D0 (no) Farmasöytiske midler
DE69820860D1 (de) Herzschrittmacher
NO20001494L (no) Overligger
DE69833493D1 (de) Gewebe
ID23250A (id) Komposisi paroksetin
ID21906A (id) Komposisi adesif
NO983090D0 (no) Terapeutiske forbindelser
ID24677A (id) Kombinasi senyawa aktif fungisidal
ID29294A (id) Komposisi farmasi
DE69836690D1 (de) Herzschrittmacher
ID25857A (id) Komposisi farmasi
DE59609922D1 (de) Wirkstoffkombinationen
DK0862850T3 (da) Mejetærsker